Publication: Pharma's Almanac
Abstract
In this Pharma’s Almanac article, Karen Rowland Yeo, Ph.D., emphasizes the role of diversity and inclusivity in clinical research in tackling global health inequities. Certara uses innovative in silico modeling approaches to optimize drug dosing for underrepresented populations, such as pregnant and lactating women.
Published: June 17, 2025
Services
Solutions
Therapeutic area
Products
Predict clinical outcomes from virtual populations
Our consultants have a proven track record in using our PBPK modeling technology for critical applications such as first-in-human (FIH) dose predictions, drug-drug interactions (DDIs), dosing for specific populations, and virtual bioequivalence.
